Monoclonal Antibody-Selected Variants of MHV-4 Contain Substitutions and Deletions in the E2 Spike Glycoprotein

  • Thomas M. Gallagher
  • Michael J. Buchmeier
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 276)


Selection and analysis of MHV-4 (strain JHM) variants resistant to E2-specific neutralizing MAbs was performed. Two types of variation in the E2 spike glycoprotein were found. From minimally passaged stocks of MHV-4, putative point mutants were obtained. These mutants were resistant only to the MAb used to select them. In contrast, multiply passaged stocks were found to harbor variants uniformly resistant to two selecting MAbs. Northern and Western blot analysis of the viral RNAs and proteins synthesized by these doubly-resistant variants showed that they contained large deletions in both mRNA 3 and its E2 translation product, localized to a 15 kilodalton region within the amino terminal 90B post-translational fragment. The selective advantage of this second class of variants lacking sequences within E2 90B was a result of their reduced cytopathology, thereby allowing cultures to support virus production for prolonged periods.


Deletion Mutant Infected Cell Protein Antipeptide Antibody Defective Interfere Murine Hepatitis Virus Type 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M.V. Haspel, P.W. Lampert, and M.B.A. Oldstone, Temperature-sensitive mutants of mouse hepatitis produce a high incidence of demyelination. Proc. Natl. Acad. Sci. USA75:4033 (1978).PubMedCrossRefGoogle Scholar
  2. 2.
    S. Stohlman, P. Brayton, J. Fleming, L. Weiner, and M. Lai, Murine coronaviruses: isolation and characterization of two plaque morphology variants of JHM neurotropic strain. J. Gen. Virol. 63:265 (1982).PubMedCrossRefGoogle Scholar
  3. 3.
    R.G. Dalziel, P.W. Lampert, P.J. Talbot, and M.J. Buchmeier, Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol. 59:463 (1986).PubMedGoogle Scholar
  4. 4.
    J.O. Fleming, M.D. Trousdale, F.A.K. El-Zaatari, S.A. Stohlman, and L.P. Weiner, Pathogenicity of antigenic variants of murine Coronavirus JHM selected with monoclonal antibodies. J. Virol. 58:869 (1986).PubMedGoogle Scholar
  5. 5.
    H. Wege, J. Winter, and R. Meyermann, The peplomer protein E2 of Coronavirus JHM as a determinant of neurovirulence: Definition of critical epitopes by variant analysis. J. Gen. Virol. 69:87 (1988).PubMedCrossRefGoogle Scholar
  6. 6.
    W. Luytjes, L.S. Sturman, P. J. Bredenbeek, J. Charite, B.A.M. van der Zeijst, M.C. Horzinek, and W.J.M. Spaan, Primary structure of the glycoprotein E2 of Coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology 161:479 (1987).PubMedCrossRefGoogle Scholar
  7. 7.
    V.L. Morris, C. Tieszer, J. Mackinnon, and D. Percy, Characterization of Coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease. Virology 169:127 (1989).PubMedCrossRefGoogle Scholar
  8. 8.
    F. Taguchi and J.O. Fleming, Comparison of six different murine Coronavirus JHM variants by monoclonal antibodies against the E2 glycoprotein. Virology 169:233 (1989).PubMedCrossRefGoogle Scholar
  9. 9.
    L.S. Sturman, K.V. Holmes, and J. Behnke, Isolation of Coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J. Virol. 33:449 (1980).PubMedGoogle Scholar
  10. 10.
    P.J. Talbot, A.A. Salmi, R.L. Knobler, and M.J. Buchmeier, Topographical mapping of epitopes on the glycoproteins of murine hepatitis virus-4 (strain JHM): Correlation with biological activities. Virology132:250 (1984).PubMedCrossRefGoogle Scholar
  11. 11.
    W.N. Burnette, Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody to radioiodinated protein A. Anal. Biochem. 112:195 (1981).PubMedCrossRefGoogle Scholar
  12. 12.
    D.A. Steinhauer and J.J. Holland, Rapid evolution of RNA viruses. Ann. Rev. Microbiol. 41:409 (1987).CrossRefGoogle Scholar
  13. 13.
    J.A. Robb and C.W. Bond, Coronaviridae, in: “Comprehensive Virology,” H. Frankel-Conrat and R.R. Wagner, eds., Plenum Publishing Corp., New York (1979).Google Scholar
  14. 14.
    A.J. Huang and D. Baltimore, Defective interfering animal viruses. Comp. Virol. 10:73 (1977).Google Scholar
  15. 15.
    M.M.C. Lai, S. Makino, L.H. Soe, C.-K. Shieh, J.G. Keck, and J.O. Fleming, Coronaviruses: A jumping RNA transcription. Cold Spring Harbor Symp. Quant. Biol. LII:359 (1987).CrossRefGoogle Scholar
  16. 16.
    R.A. Lazzarini, J.D. Keene, and M. Schubert, The origins of defective interfering particles of the negative strand RNA viruses. Cell 26:145 (1981).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Thomas M. Gallagher
    • 1
  • Michael J. Buchmeier
    • 1
  1. 1.Department of NeuropharmacologyScripps Clinic and Research FoundationLa JollaUSA

Personalised recommendations